Fujifilm to partner with Dr. Reddy’s to sell Avigan overseas as Coronavirus treatment

Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo

Fujifilm Holdings Corp said on Wednesday it was partnering with Dr Reddy’s Laboratories to sell the anti-flu drug Avigan in India and elsewhere to treat COVID-19, the respiratory disease caused by the coronavirus.

The agreement provides for Fujifilm Toyama Chemical, a unit of the Japanese company to grant Dr. Reddy’s and Dubai-based Global Response Aid the right to develop, make and sell Avigan overseas and get a lump-sum license fee and royalties on sales.

Was it worth reading? Let us know.